These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21490953)

  • 1. SUMO-interacting motifs of human TRIM5α are important for antiviral activity.
    Arriagada G; Muntean LN; Goff SP
    PLoS Pathog; 2011 Apr; 7(4):e1002019. PubMed ID: 21490953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of SUMO-1 and SUMO interacting motifs in rhesus TRIM5α-mediated restriction.
    Lukic Z; Goff SP; Campbell EM; Arriagada G
    Retrovirology; 2013 Feb; 10():10. PubMed ID: 23369348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM5α is a SUMO substrate.
    Dutrieux J; Portilho DM; Arhel NJ; Hazan U; Nisole S
    Retrovirology; 2015 Mar; 12():28. PubMed ID: 25880753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of SUMO-interacting motifs and SUMOylation to the antiretroviral properties of TRIM5α.
    Brandariz-Nuñez A; Roa A; Valle-Casuso JC; Biris N; Ivanov D; Diaz-Griffero F
    Virology; 2013 Jan; 435(2):463-71. PubMed ID: 23084420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
    Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
    Perron MJ; Stremlau M; Lee M; Javanbakht H; Song B; Sodroski J
    J Virol; 2007 Mar; 81(5):2138-48. PubMed ID: 17135314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.
    Perron MJ; Stremlau M; Sodroski J
    J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
    Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
    PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
    Diaz-Griffero F; Perron M; McGee-Estrada K; Hanna R; Maillard PV; Trono D; Sodroski J
    Virology; 2008 Sep; 378(2):233-42. PubMed ID: 18586294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
    Ulm JW; Perron M; Sodroski J; C Mulligan R
    Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
    Yap MW; Nisole S; Lynch C; Stoye JP
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10786-91. PubMed ID: 15249690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
    Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
    J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
    Oliveira NM; Trikha R; McKnight Á
    Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of N-tropic mutant porcine endogenous retrovirus infectivity by human tripartite motif-containing 5-isoform alpha.
    Lee J; Cho YD; Heo YK; Kwon Y; Kim DG; Choi BS; Kim SS; Kim YB
    Transplant Proc; 2011 Sep; 43(7):2774-8. PubMed ID: 21911161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
    Maillard PV; Reynard S; Serhan F; Turelli P; Trono D
    PLoS Pathog; 2007 Dec; 3(12):e200. PubMed ID: 18166079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.
    Roa A; Hayashi F; Yang Y; Lienlaf M; Zhou J; Shi J; Watanabe S; Kigawa T; Yokoyama S; Aiken C; Diaz-Griffero F
    J Virol; 2012 Feb; 86(3):1717-27. PubMed ID: 22114335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.
    Conn KL; Wasson P; McFarlane S; Tong L; Brown JR; Grant KG; Domingues P; Boutell C
    J Virol; 2016 May; 90(9):4807-4826. PubMed ID: 26937035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.
    Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP
    J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner.
    Maillet S; Fernandez J; Decourcelle M; El Koulali K; Blanchet FP; Arhel NJ; Maarifi G; Nisole S
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32545337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
    Rold CJ; Aiken C
    PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.